All Stories

  1. Redefining Peptide 14D: Substitutional Analysis for Accelerated TB Diagnosis and Enhanced Activity against Mycobacterium tuberculosis
  2. Specific Cationic Antimicrobial Peptides Enhance the Recovery of Low-Load Quiescent Mycobacterium tuberculosis in Routine Diagnostics
  3. Redefining Peptide 14D: Substitutional Analysis for Accelerated TB Diagnosis and Enhanced Activity against Mycobacterium Tuberculosis
  4. Discovery of Antimicrobial Peptides That Can Accelerate Culture Diagnostics of Slow-Growing Mycobacteria Including Mycobacterium tuberculosis
  5. Discovery of Antimicrobial Peptides That Can Accelerate the Diagnostics of Slow-Growing Mycobacteria Including Mycobacterium Tuberculosis by Culture
  6. Can BioSAXS detect ultrastructural changes of antifungal compounds in Candida albicans?–an exploratory study
  7. Can BioSAXS Detect Ultrastructural Changes Of Antifungal Compounds InCandida Albicans? – An Exploratory Study
  8. Rational Designed Hybrid Peptides Show up to a 6-Fold Increase in Antimicrobial Activity and Demonstrate Different Ultrastructural Changes as the Parental Peptides Measured by BioSAXS
  9. Rational Designed Hybrid Peptides Show up to a 6-fold Increase in Antimicrobial Activity and Demonstrate Different Ultrastructural Changes as the Parental Peptides measured by BioSAXS
  10. Peptides that are used in COVID-19 Clinical Trials — A Snapshot
  11. Is the Gut Microbiome a Target for Adjuvant Treatment of COVID-19?
  12. Is There a Connection Between Gut Microbiome Dysbiosis in COVID-19 and Post-COVID-19 Symptoms?
  13. Rapid Assembly of Infection-Resistant Coatings: Screening and Identification of Antimicrobial Peptides Works in Cooperation with an Antifouling Background
  14. Comparison of a Short Linear Antimicrobial Peptide with Its Disulfide-Cyclized and Cyclotide-Grafted Variants against Clinically Relevant Pathogens
  15. Antimicrobial Activity Of A Histone Derived Peptide In The Airway Surface Liquid
  16. Peptide Inhibitors of Bacterial Protein Synthesis with Broad Spectrum and SbmA-Independent Bactericidal Activity against Clinical Pathogens
  17. Identification Of A Novel Histone Derived Antimicrobial Peptide In Airway Surface Liquid.
  18. The effect of lipidation and glycosylation on short cationic antimicrobial peptides
  19. Front Cover: Proline‐Rich Peptides with Improved Antimicrobial Activity against E. coli , K. pneumoniae , and A. baumannii (ChemMedChem 24/2019)
  20. Synergy Pattern of Short Cationic Antimicrobial Peptides Against Multidrug-Resistant Pseudomonas aeruginosa
  21. Proline‐Rich Peptides with Improved Antimicrobial Activity against E. coli , K. pneumoniae , and A. baumannii
  22. Two antimicrobial peptides induce similar molecular changes in bacteria
  23. Poster Session
  24. In silicoidentification of novel peptides with antibacterial activity against multidrug resistantStaphylococcus aureus
  25. In silico identification of two novel antimicrobial peptides with antibacterial activity against multi-drug resistant Staphylococcus aureus
  26. The Savage Dawn Peptide: an antibiotic woven from 12th century Welsh poetry
  27. The Dolphin Proline-Rich Antimicrobial Peptide Tur1A Inhibits Protein Synthesis by Targeting the Bacterial Ribosome
  28. The rumen microbiome: an underexplored resource for novel antimicrobial discovery
  29. Buwchitin: A Ruminal Peptide with Antimicrobial Potential against Enterococcus faecalis
  30. A short artificial antimicrobial peptide shows potential to prevent or treat bone infections
  31. Screening and Optimizing Antimicrobial Peptides by Using SPOT-Synthesis
  32. Improved Culture Medium (TiKa) for Mycobacterium avium Subspecies Paratuberculosis (MAP) Matches qPCR Sensitivity and Reveals Significant Proportions of Non-viable MAP in Lymphoid Tissue of Vaccinated MAP Challenged Animals
  33. Use of Peptide Libraries for Identification and Optimization of Novel Antimicrobial Peptides
  34. Molecular changes in E. coli after treatment with different antibiotics
  35. Antimicrobial peptides: Cell Membrane and Microbial Surface Interactions
  36. Improving short antimicrobial peptides despite elusive rules for activity
  37. Small angle X-ray scattering as a high-throughput method to classify antimicrobial modes of action
  38. Alternatives to antibiotics—a pipeline portfolio review
  39. Interaction of blood components with cathelicidins and their modified versions
  40. Optimization of oncocin for antibacterial activity using a SPOT synthesis approach: extending the pathogen spectrum to Staphylococcus aureus
  41. Cationic antimicrobial peptides as potential new therapeutic agents in neonates and children
  42. Targeting Mycobacterium tuberculosis and Other Microbial Pathogens Using Improved Synthetic Antibacterial Peptides
  43. A Novel Monoclonal Antibody Against the C-terminus of β-Tubulin Recognizes Endocytic Organelles in Trypanosoma cruzi
  44. The biocompatibility and biofilm resistance of implant coatings based on hydrophilic polymer brushes conjugated with antimicrobial peptides
  45. Identifying Novel Antimicrobial Peptides with Therapeutic Potential Against Multidrug-Resistant Bacteria by Using the SPOT Synthesis
  46. SPOT Synthesis as a Tool to Study Protein–Protein Interactions
  47. Screening for Antifungal Peptides and Their Modes of Action in Aspergillus nidulans
  48. Structural Studies of a Peptide with Immune Modulating and Direct Antimicrobial Activity
  49. Short Cationic Antimicrobial Peptides Interact with ATP
  50. Easy Strategy To Protect Antimicrobial Peptides from Fast Degradation in Serum
  51. Posters
  52. Synthesis of Antimicrobial Peptides Using the SPOT Technique
  53. High-Throughput Screening for Antimicrobial Peptides Using the SPOT Technique
  54. Synergistic Interaction between Silver Nanoparticles and Membrane-Permeabilizing Antimicrobial Peptides
  55. Identification of Novel Antibacterial Peptides by Chemoinformatics and Machine Learning †
  56. Interpretable Features for the Activity Prediction of Short Antimicrobial Peptides Using Fuzzy Logic
  57. Use of Artificial Intelligence in the Design of Small Peptide Antibiotics Effective against a Broad Spectrum of Highly Antibiotic-Resistant Superbugs
  58. Synthesis of Peptide Arrays Using SPOT-Technology and the CelluSpots-Method
  59. Screening and Characterization of Surface-Tethered Cationic Peptides for Antimicrobial Activity
  60. Identification of novel host defense peptides and the absence of α-defensins in the bovine genome
  61. Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances
  62. X-ray spectromicroscopy study of competitive adsorption of protein and peptide onto polystyrene-poly(methyl methacrylate)
  63. Short Linear Cationic Antimicrobial Peptides: Screening, Optimizing, and Prediction
  64. Evaluating Different Descriptors for Model Design of Antimicrobial Peptides with Enhanced Activity Toward P. aeruginosa
  65. Using Intrinsic X-ray Absorption Spectral Differences To Identify and Map Peptides and Proteins
  66. Use of luminescent bacteria for rapid screening and characterization of short cationic antimicrobial peptides synthesized on cellulose using peptide array technology
  67. Peptide arrays on cellulose support: SPOT synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion
  68. Sequence Requirements and an Optimization Strategy for Short Antimicrobial Peptides
  69. Complete Substitutional Analysis of a Sunflower Trypsin Inhibitor with Different Serine Proteases
  70. High-throughput generation of small antibacterial peptides with improved activity
  71. Unraveling Sub-Site Specificities of Peptidic Serine Protease Inhibitors by Substitutional and Structural Analysis
  72. Crystallization and Preliminary X-ray Analysis of Complexes of Porcine Pancreatic Elastase with two Natural Inhibitors
  73. Design and Characterization of a Hybrid Miniprotein That Specifically Inhibits Porcine Pancreatic Elastase
  74. Structure of a hybrid squash inhibitor in complex with porcine pancreatic elastase at 1.8 Å resolution
  75. Crystallization and preliminary X-ray analysis of the complex of porcine pancreatic elastase and a hybrid squash inhibitor
  76. Anti-c-myc antibody 9E10: epitope key positions and variability characterized using peptide spot synthesis on cellulose
  77. Characterizing and Optimizing Protease/Peptide Inhibitor Interactions, a New Application for Spot Synthesis
  78. Atomic resolution structure of native porcine pancreatic elastase at 1.1 Å
  79. Interaction of the Capsid Protein p24 (HIV-1) with Sequence-Derived Peptides: Influence on p24 Dimerization